Medical application of cytosine derivative

The invention provides a compound (I) or pharmaceutically acceptable salts, esters, optical isomers, tautomers, stereoisomers, polymorphs, solvates, N-oxides, isotope labeled compounds, metabolites, chelates, complexes, clathrates or prodrugs thereof, and a pharmaceutical composition containing the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CAO BINWANG, ZHANG DONGNA, XU LIKUN, WANG BAOGANG, SONG YABIN, BEI ZHUCHUN, ZHAO LIANGLIANG
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CAO BINWANG
ZHANG DONGNA
XU LIKUN
WANG BAOGANG
SONG YABIN
BEI ZHUCHUN
ZHAO LIANGLIANG
description The invention provides a compound (I) or pharmaceutically acceptable salts, esters, optical isomers, tautomers, stereoisomers, polymorphs, solvates, N-oxides, isotope labeled compounds, metabolites, chelates, complexes, clathrates or prodrugs thereof, and a pharmaceutical composition containing the compound. Also provided are uses of the compounds of the invention as double-stranded DNA virus inhibitors. 本发明提供了化合物(I)或者其药学上可接受的盐、酯、光学异构体、互变异构体、立体异构体、多晶型物、溶剂合物、N-氧化物、同位素标记的化合物、代谢物、螯合物、络合物、包合物或前药,以及含有本发明的化合物的药物组合物,还提供本发明化合物作为双链DNA病毒抑制剂的用途。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN118845799A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN118845799A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN118845799A3</originalsourceid><addsrcrecordid>eNrjZNDyTU3JTE7MUUgsKMgBMkoy8_MU8tMUkitL8osz81IVUlKLMsuAwmWpPAysaYk5xam8UJqbQdHNNcTZQze1ID8-tbggMTk1L7Uk3tnP0NDCwsTU3NLS0ZgYNQBLiyly</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Medical application of cytosine derivative</title><source>esp@cenet</source><creator>CAO BINWANG ; ZHANG DONGNA ; XU LIKUN ; WANG BAOGANG ; SONG YABIN ; BEI ZHUCHUN ; ZHAO LIANGLIANG</creator><creatorcontrib>CAO BINWANG ; ZHANG DONGNA ; XU LIKUN ; WANG BAOGANG ; SONG YABIN ; BEI ZHUCHUN ; ZHAO LIANGLIANG</creatorcontrib><description>The invention provides a compound (I) or pharmaceutically acceptable salts, esters, optical isomers, tautomers, stereoisomers, polymorphs, solvates, N-oxides, isotope labeled compounds, metabolites, chelates, complexes, clathrates or prodrugs thereof, and a pharmaceutical composition containing the compound. Also provided are uses of the compounds of the invention as double-stranded DNA virus inhibitors. 本发明提供了化合物(I)或者其药学上可接受的盐、酯、光学异构体、互变异构体、立体异构体、多晶型物、溶剂合物、N-氧化物、同位素标记的化合物、代谢物、螯合物、络合物、包合物或前药,以及含有本发明的化合物的药物组合物,还提供本发明化合物作为双链DNA病毒抑制剂的用途。</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241029&amp;DB=EPODOC&amp;CC=CN&amp;NR=118845799A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241029&amp;DB=EPODOC&amp;CC=CN&amp;NR=118845799A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CAO BINWANG</creatorcontrib><creatorcontrib>ZHANG DONGNA</creatorcontrib><creatorcontrib>XU LIKUN</creatorcontrib><creatorcontrib>WANG BAOGANG</creatorcontrib><creatorcontrib>SONG YABIN</creatorcontrib><creatorcontrib>BEI ZHUCHUN</creatorcontrib><creatorcontrib>ZHAO LIANGLIANG</creatorcontrib><title>Medical application of cytosine derivative</title><description>The invention provides a compound (I) or pharmaceutically acceptable salts, esters, optical isomers, tautomers, stereoisomers, polymorphs, solvates, N-oxides, isotope labeled compounds, metabolites, chelates, complexes, clathrates or prodrugs thereof, and a pharmaceutical composition containing the compound. Also provided are uses of the compounds of the invention as double-stranded DNA virus inhibitors. 本发明提供了化合物(I)或者其药学上可接受的盐、酯、光学异构体、互变异构体、立体异构体、多晶型物、溶剂合物、N-氧化物、同位素标记的化合物、代谢物、螯合物、络合物、包合物或前药,以及含有本发明的化合物的药物组合物,还提供本发明化合物作为双链DNA病毒抑制剂的用途。</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDyTU3JTE7MUUgsKMgBMkoy8_MU8tMUkitL8osz81IVUlKLMsuAwmWpPAysaYk5xam8UJqbQdHNNcTZQze1ID8-tbggMTk1L7Uk3tnP0NDCwsTU3NLS0ZgYNQBLiyly</recordid><startdate>20241029</startdate><enddate>20241029</enddate><creator>CAO BINWANG</creator><creator>ZHANG DONGNA</creator><creator>XU LIKUN</creator><creator>WANG BAOGANG</creator><creator>SONG YABIN</creator><creator>BEI ZHUCHUN</creator><creator>ZHAO LIANGLIANG</creator><scope>EVB</scope></search><sort><creationdate>20241029</creationdate><title>Medical application of cytosine derivative</title><author>CAO BINWANG ; ZHANG DONGNA ; XU LIKUN ; WANG BAOGANG ; SONG YABIN ; BEI ZHUCHUN ; ZHAO LIANGLIANG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN118845799A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2024</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CAO BINWANG</creatorcontrib><creatorcontrib>ZHANG DONGNA</creatorcontrib><creatorcontrib>XU LIKUN</creatorcontrib><creatorcontrib>WANG BAOGANG</creatorcontrib><creatorcontrib>SONG YABIN</creatorcontrib><creatorcontrib>BEI ZHUCHUN</creatorcontrib><creatorcontrib>ZHAO LIANGLIANG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CAO BINWANG</au><au>ZHANG DONGNA</au><au>XU LIKUN</au><au>WANG BAOGANG</au><au>SONG YABIN</au><au>BEI ZHUCHUN</au><au>ZHAO LIANGLIANG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Medical application of cytosine derivative</title><date>2024-10-29</date><risdate>2024</risdate><abstract>The invention provides a compound (I) or pharmaceutically acceptable salts, esters, optical isomers, tautomers, stereoisomers, polymorphs, solvates, N-oxides, isotope labeled compounds, metabolites, chelates, complexes, clathrates or prodrugs thereof, and a pharmaceutical composition containing the compound. Also provided are uses of the compounds of the invention as double-stranded DNA virus inhibitors. 本发明提供了化合物(I)或者其药学上可接受的盐、酯、光学异构体、互变异构体、立体异构体、多晶型物、溶剂合物、N-氧化物、同位素标记的化合物、代谢物、螯合物、络合物、包合物或前药,以及含有本发明的化合物的药物组合物,还提供本发明化合物作为双链DNA病毒抑制剂的用途。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN118845799A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Medical application of cytosine derivative
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A42%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CAO%20BINWANG&rft.date=2024-10-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN118845799A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true